The anti-COVID-19 intramuscular vaccination induces a strong systemic but a weak mucosal immune response in adults. Little is known about the mucosal immune response in children infected or vaccinated against SARS-CoV-2. We found that 28% of children had detectable salivary IgA against SARS-CoV-2 even before vaccination, suggesting that, in children, SARS-CoV-2 infection may be undiagnosed. After vaccination, only receptor-binding domain (RBD)–specific IgA1 significantly increased in the saliva. Conversely, infected children had significantly higher salivary RBD-IgA2 compared to IgA1, indicating that infection more than vaccination induces a specific mucosal immune response in children. Future efforts should focus on development of vaccine technologies that also activate mucosal immunity.
SARS-CoV-2–specific mucosal immune response in vaccinated versus infected children / Conti, M.G., Piano Mortari, E., Nenna, R., Pierangeli, A., Sorrentino, L., Frasca, F., Petrarca, L., Mancino, E., Di Mattia, G., Matera, L., Fracella, M., Albano, C., Scagnolari, C., Capponi, M., Cinicola, B., Carsetti, R., Midulla, F.. - In: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. - ISSN 2235-2988. - 14:(2024). [10.3389/fcimb.2024.1231697]
SARS-CoV-2–specific mucosal immune response in vaccinated versus infected children
Conti, Maria Giulia
Primo
;Piano Mortari, Eva;Nenna, Raffaella;Pierangeli, Alessandra;Sorrentino, Leonardo;Frasca, Federica;Petrarca, Laura;Mancino, Enrica;Di Mattia, Greta;Matera, Luigi;Fracella, Matteo;Scagnolari, Carolina;Capponi, Martina;Cinicola, Bianca;Midulla, FabioUltimo
2024
Abstract
The anti-COVID-19 intramuscular vaccination induces a strong systemic but a weak mucosal immune response in adults. Little is known about the mucosal immune response in children infected or vaccinated against SARS-CoV-2. We found that 28% of children had detectable salivary IgA against SARS-CoV-2 even before vaccination, suggesting that, in children, SARS-CoV-2 infection may be undiagnosed. After vaccination, only receptor-binding domain (RBD)–specific IgA1 significantly increased in the saliva. Conversely, infected children had significantly higher salivary RBD-IgA2 compared to IgA1, indicating that infection more than vaccination induces a specific mucosal immune response in children. Future efforts should focus on development of vaccine technologies that also activate mucosal immunity.| File | Dimensione | Formato | |
|---|---|---|---|
|
Conti_Mucosal-response_2024.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
1.14 MB
Formato
Adobe PDF
|
1.14 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
